Neuroscience Virtual Partnering: 9-12 November, 2020
During four days of face-to-face online meetings, leading researchers, top biotechs and biopharmaceutical companies will meet, network and partner to accelerate neuroscience pipelines and bring new treatment options to patients worldwide.
“As Orion is working on innovative technologies for neuroscience, this is the partnering opportunity we were looking for: 4 days of one-to-one meetings focused solely on neuroscience. We look forward to meetings with other neuroscience focused companies on 9-12 November”
“Avilex Pharma is coming to Neuroscience Virtual Partnering to present our latest ground-breaking treatments of brain diseases in this therapeutic area. The targeted one-on-one meetings focused solely on neuroscience will help us identify partners to take them forward”
“We're excited to explore new partnering opportunities in neuroscience during the upcoming Neuroscience Virtual Partnering Event 9-12 November, which has gathered quality attendees already.”
“We're delighted to take part in the Neuroscience Virtual Partnering Event that gathers the top life science companies researching and developing treatments in neuroscience. The pandemic has limited our ability to travel and present our research to relevant representatives from pharma companies and we're happy for the opportunity to do so now in a virtual format!”
About this conference
Where the best science comes to meet
With the Neuroscience Virtual Partnering Event, our aim is to create the connections between biotech companies and pharmaceutical companies, increasing the chances for biotechs to succeed.
From 9-12 November, Inova in collaboration with Biotechnology Innovation Organization (BIO), are organizing a 4-day virtual partnering event on neuroscience where participants will have the opportunity to network using the partnering platform and showcase their companies through short video presentations or through links to their scientific abstracts.
Through one-on-one meetings, they will discuss the latest research from neurology congresses, learn about emerging start-ups, pitch ideas and partner to prioritize research efforts that hold the most promise.
Participants will be exchanging about topics such as neurodegenerative, neurological and psychiatric diseases, chronic pain, Huntington’s disease, epilepsy, multiple sclerosis, stroke, Alzheimer's disease, traumatic brain injury, amyotrophic lateral sclerosis, neurological rare diseases, spinal muscular atrophy and other central and peripheral nervous system disorders.
This event will leverage Inova and BIO’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.
What is a virtual Partnering Event?
It’s a conference of virtual face-to-face meetings. All meetings are online instead of at a physical location.
Who will attend?
Pharma & Biotech
Diagnostic & Biomarkers
Carrier Systems & Formulation
The Virtual Partnering Event will bring these stakeholders together to pursue:
Registration for the Neuroscience Virtual Partnering event opens on 21 September. Then, our partnering platform, One-on-One Partnering, will open on 22 October so that participants will have up to two and a half weeks to make connections and request online meetings. On 9 November the virtual partnering starts with online scheduled meetings for four days through 12 November.
21 September 2020
Registration for the Virtual
Partnering Event starts.
22 October 2020
Platform is open
Participants can begin
sending meeting requests.
Scheduled meetings will
take place online.
About the Virtual Partnering Platform
This event will leverage Inova and BIO's matchmaking platform, One-on-One Partnering™, that has been at the heart of major international biopharmaceutical conventions since 2015. It’s the leading partnering system that facilitates thousands of face-to-face meetings at dozens of biopharma conferences worldwide including the BIO International Convention, BIO Digital and BIO Asia. For instance, in the weeks before the BIO International Convention, 4,000 biopharma companies connect online, list their technologies and capabilities, and request meetings with potential partners. By the time the Convention opens thousands of relevant meetings are scheduled – almost 50,000 at BIO Convention 2019 alone.